Main Menu
Menu

Bloomberg Law

Publish Date
News
Patent Judges Review Fewer Challenges as Agency Priorities Shift
Bloomberg Law
BlogOp-Eds
Patent Eligibility Restoration Act Would Fuel US Competitiveness

In a recent op-ed for Bloomberg Law, C4IP Board Members and retired Federal Circuit Judges Paul Michel and Kathleen O’Malley argue that...

Bloomberg Law
Op-Eds
White House’s Drug Patent Plan Undercuts Research and Innovation

Merrill Matthews, a resident scholar with the Institute for Policy Innovation, recently published an opinion piece in RealClearHealth calling attention to the...

Bloomberg Law
News
Ex-Patent, Commerce Officials Ask Biden to Skip Covid IP Waiver

Former Department of Commerce and US Patent and Trademark Office officials urged President Joe Biden to oppose a World Trade Organization proposal...

Bloomberg Law
Op-Eds
Patent Office Rulemaking Can Curb Abuses via America Invents Act
Bloomberg Law
Op-Eds
House Patent Troll Bill Would Shield Pirates, Not Small Inventors
Bloomberg Law
Op-Eds
Don’t Know if Your Child Has Strep? Thank the U.S. Supreme Court
Bloomberg Law
Op-Eds
Humira Shows That America’s Patent Innovation System Is Working
Bloomberg Law
Op-Eds
Scapegoating Patents Won’t Lower Drug Prices

In their quest to lower drug prices, some US leaders have identified a convenient scapegoat: patents.

...
Bloomberg Law
News:

News:

Patent Judges Review Fewer Challenges as Agency Priorities Shift,

08/11/2025
Op-Eds:

Blog, Op-Eds:

Patent Eligibility Restoration Act Would Fuel US Competitiveness,

07/09/2025
Op-Eds:

Op-Eds:

White House’s Drug Patent Plan Undercuts Research and Innovation,

01/09/2024
News:

News:

Ex-Patent, Commerce Officials Ask Biden to Skip Covid IP Waiver,

12/05/2023
Op-Eds:

Op-Eds:

Patent Office Rulemaking Can Curb Abuses via America Invents Act,

07/19/2023
Op-Eds:

Op-Eds:

House Patent Troll Bill Would Shield Pirates, Not Small Inventors,

06/14/2023
Op-Eds:

Op-Eds:

Don’t Know if Your Child Has Strep? Thank the U.S. Supreme Court,

05/31/2023
Op-Eds:

Op-Eds:

Humira Shows That America’s Patent Innovation System Is Working,

02/24/2023
Op-Eds:

Op-Eds:

Scapegoating Patents Won’t Lower Drug Prices,

10/17/2022
Scroll to Top